CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$24,711
+15.7%
30,5070.0%0.00%
Q1 2023$21,355
-0.8%
30,5070.0%0.00%
Q4 2022$21,538
-54.2%
30,5070.0%0.00%
Q3 2022$47,000
-62.7%
30,507
-64.9%
0.00%
Q1 2022$126,000
-72.3%
86,9750.0%0.00%
Q4 2021$455,000
-10.4%
86,9750.0%0.00%
Q3 2021$508,000
-73.3%
86,975
-63.2%
0.00%
-100.0%
Q2 2021$1,905,000
+12.8%
236,347
+16.4%
0.00%0.0%
Q1 2021$1,689,000
+10.5%
202,998
+0.7%
0.00%0.0%
Q4 2020$1,529,000
-27.7%
201,603
+1.6%
0.00%0.0%
Q3 2020$2,116,000
-25.0%
198,438
+6.6%
0.00%0.0%
Q2 2020$2,822,000
+102.7%
186,130
+11.4%
0.00%0.0%
Q1 2020$1,392,000
-50.2%
167,080
+1.1%
0.00%
-50.0%
Q4 2019$2,793,000
-7.2%
165,231
+2.0%
0.00%0.0%
Q3 2019$3,009,000
-14.6%
161,994
+5.2%
0.00%0.0%
Q2 2019$3,524,000
+11.6%
154,013
+2.5%
0.00%0.0%
Q1 2019$3,159,000
+93.3%
150,277
+5.8%
0.00%
+100.0%
Q4 2018$1,634,000
-50.8%
142,068
-1.7%
0.00%
-50.0%
Q3 2018$3,318,000
+10.4%
144,570
+7.3%
0.00%0.0%
Q2 2018$3,005,000
-1.0%
134,732
+1.5%
0.00%0.0%
Q1 2018$3,034,000
-10.1%
132,777
+3.1%
0.00%
-33.3%
Q4 2017$3,375,000
+21.7%
128,814
+4.3%
0.00%
+50.0%
Q3 2017$2,774,000
-13.5%
123,537
+5.4%
0.00%
-33.3%
Q2 2017$3,207,000
+21.2%
117,236
+7.3%
0.00%0.0%
Q1 2017$2,646,000
+23.2%
109,306
+5.6%
0.00%
+50.0%
Q4 2016$2,148,000
-15.5%
103,510
+11.1%
0.00%
-33.3%
Q3 2016$2,541,000
+79.3%
93,187
-5.3%
0.00%
+50.0%
Q2 2016$1,417,000
-0.9%
98,416
-1.1%
0.00%0.0%
Q1 2016$1,430,000
-11.1%
99,506
+32.9%
0.00%0.0%
Q4 2015$1,609,000
+30.9%
74,857
-1.4%
0.00%0.0%
Q3 2015$1,229,000
-36.6%
75,906
+1.1%
0.00%
-33.3%
Q2 2015$1,937,000
+18.1%
75,044
+3.0%
0.00%
+50.0%
Q1 2015$1,640,000
+46.6%
72,852
+25.0%
0.00%0.0%
Q4 2014$1,119,000
-8.5%
58,300
+2.5%
0.00%0.0%
Q3 2014$1,223,000
+21.8%
56,897
+47.4%
0.00%0.0%
Q2 2014$1,004,000
+210.8%
38,600
+160.8%
0.00%
+100.0%
Q1 2014$323,000
+78.5%
14,8000.0%0.00%
Q4 2013$181,000
-6.2%
14,8000.0%0.00%
Q3 2013$193,000
+62.2%
14,8000.0%0.00%
Q2 2013$119,00014,8000.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders